Logo image of PLRZ

POLYRIZON LTD (PLRZ) Stock Price, Forecast & Analysis

USA - NASDAQ:PLRZ - IL0011814113 - Common Stock

1.03 USD
0 (0%)
Last: 10/31/2025, 9:32:37 AM

PLRZ Key Statistics, Chart & Performance

Key Statistics
Market Cap6.17M
Revenue(TTM)N/A
Net Income(TTM)-1782000
Shares5.99M
Float5.99M
52 Week High1200
52 Week Low0.55
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-134.31
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO2024-10-29
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


PLRZ short term performance overview.The bars show the price performance of PLRZ in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60 -80

PLRZ long term performance overview.The bars show the price performance of PLRZ in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of PLRZ is 1.03 USD. In the past month the price decreased by -5.5%. In the past year, price decreased by -99.65%.

POLYRIZON LTD / PLRZ Daily stock chart

PLRZ Latest News, Press Relases and Analysis

PLRZ Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 20.76 388.38B
AMGN AMGEN INC 13.31 156.26B
GILD GILEAD SCIENCES INC 14.51 147.43B
VRTX VERTEX PHARMACEUTICALS INC 24.61 106.88B
REGN REGENERON PHARMACEUTICALS 14.43 68.84B
ALNY ALNYLAM PHARMACEUTICALS INC 343.06 58.46B
ARGX ARGENX SE - ADR 61.3 50.01B
INSM INSMED INC N/A 41.43B
ONC BEONE MEDICINES LTD-ADR 5.03 34.24B
NTRA NATERA INC N/A 26.64B
BNTX BIONTECH SE-ADR N/A 24.84B
BIIB BIOGEN INC 8.87 21.77B

About PLRZ

Company Profile

PLRZ logo image Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. The firm is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The firm is focused not only on the development of intranasal products, but also on commercialization. The firm cooperates with medical specialists and researchers..

Company Info

POLYRIZON LTD

HaTidhar St. 5

Ra'anana IL

Employees: 1

PLRZ Company Website

PLRZ Investor Relations

Phone: 97293740120

POLYRIZON LTD / PLRZ FAQ

Can you describe the business of POLYRIZON LTD?

Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. The firm is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The firm is focused not only on the development of intranasal products, but also on commercialization. The firm cooperates with medical specialists and researchers..


What is the stock price of POLYRIZON LTD today?

The current stock price of PLRZ is 1.03 USD.


What is the dividend status of POLYRIZON LTD?

PLRZ does not pay a dividend.


What is the ChartMill technical and fundamental rating of PLRZ stock?

PLRZ has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


PLRZ Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

PLRZ Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to PLRZ. PLRZ has a great financial health rating, but its profitability evaluates not so good.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PLRZ Financial Highlights

Over the last trailing twelve months PLRZ reported a non-GAAP Earnings per Share(EPS) of -134.31. The EPS decreased by -74.28% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -9.51%
ROE -9.7%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%99.67%
Sales Q2Q%N/A
EPS 1Y (TTM)-74.28%
Revenue 1Y (TTM)N/A

PLRZ Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

PLRZ Ownership

Ownership
Inst Owners6.19%
Ins Owners0.01%
Short Float %3.82%
Short Ratio0.17